Can I read Sclerostin Inhibitors for Osteoporosis Treatment on EtoBox?
Sclerostin Inhibitors for Osteoporosis Treatment by amalabdulaali is a document available to read on EtoBox.
What is Sclerostin Inhibitors for Osteoporosis Treatment about?
The article discusses the role of sclerostin inhibition as a new therapeutic approach for treating postmenopausal osteoporosis, highlighting the significance of the Wnt signaling pathway in bone formation. Romosozumab, a monoclonal antibody targeting sclerostin, has shown efficacy in increasing bone formation and reducing fracture risk, and has been approved by the FDA for clinical use. However, caution is advised for patients with a high risk of cardiovascular events when prescribing this treatment.
- Author
- amalabdulaali
- Language
- EN